SCHEMBL690728

SCHEMBL690728

Nc1cc(N(c2ccccc2)c2cccc(N)n2)ncn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASIC3 Q9UHC3 2/20 0.40
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
EGFR P00533 5/20 0.34
NPC1 O15118 1/20 0.34
JAK2 O60674 1/20 0.34
RAB9A P51151 1/20 0.34
DHFR P00374 1/20 0.33
PDPK1 O15530 1/20 0.33
NCF1 P14598 1/20 0.32
GRM4 Q14833 1/20 0.32
CSF1R P07333 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12176971 0.82 ASIC3 (0.45) ASIC3MAPTALDH1A1TDP1KDM4E
SCHEMBL690517 0.79 MAPK1 (0.36) EGFR
SCHEMBL16102991 0.70 HSP90AA1 (0.42) ASIC3MAPTALDH1A1KDM4ECYP2D6
SCHEMBL1518829 0.69 IRAK4 (0.44) MAPTKDM4EL3MBTL1SMN1; SMN2KMT2A
SCHEMBL17032805 0.68 ALDH1A1 (0.46) MAPTALDH1A1TDP1KDM4ECYP1A2
SCHEMBL1518926 0.66 KHK (0.39) MAPTALDH1A1TDP1KDM4ECYP1A2
SCHEMBL27907258 0.66 EGFR (0.44) ASIC3MAPTALDH1A1EGFRCSF1R
SCHEMBL23351082 0.65 MAPT (0.41) MAPTALDH1A1TDP1KDM4ECYP1A2
SCHEMBL26028769 0.65 ALDH1A1 (0.45) MAPTALDH1A1TDP1KDM4ECYP1A2
SCHEMBL21075886 0.64 ALDH1A1 (0.48) MAPTALDH1A1TDP1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421538-A1 HETEROARYL COMPOUNDS AND USES THEREOF Avila Therapeutics, Inc. (US) 2012-02-29 EP disclosed
WO-2010123870-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-10-28 WO disclosed